Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aromatase inhibitors in the treatment of advanced breast cancer.

× No keyword cloud information.

11 in total

Review 1. Clinical pharmacokinetics of aromatase inhibitors and inactivators.

Authors: Per Lønning
Journal: Clin Pharmacokinet Date: 2003 Impact factor: 6.447

Review 2. Systemic therapy of advanced breast cancer.

Authors: H T Mouridsen
Journal: Drugs Date: 1992 Impact factor: 9.546

Review 3. Aromatase inhibitors and inactivators for breast cancer therapy.

Authors: Per E Lønning
Journal: Drugs Aging Date: 2002 Impact factor: 3.923

Review 4. Exemestane: a review of its use in postmenopausal women with advanced breast cancer.

Authors: D Clemett; H M Lamb
Journal: Drugs Date: 2000-06 Impact factor: 9.546

Review 5. New generation aromatase inhibitors in breast cancer. Weighing out potential costs and benefits.

Authors: G M Higa
Journal: Pharmacoeconomics Date: 2000-02 Impact factor: 4.981

Review 6. First generation aromatase inhibitors--aminoglutethimide and testololactone.

Authors: G Cocconi
Journal: Breast Cancer Res Treat Date: 1994 Impact factor: 4.872

7. Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years.

Authors: Naoko Honma; Kaiyo Takubo; Motoji Sawabe; Tomio Arai; Futoshi Akiyama; Goi Sakamoto; Toshiaki Utsumi; Noriko Yoshimura; Nobuhiro Harada
Journal: Breast Cancer Res Date: 2009-07-10 Impact factor: 6.466

8. Adverse Outcome Pathway Network-Based Assessment of the Interactive Effects of an Androgen Receptor Agonist and an Aromatase Inhibitor on Fish Endocrine Function.

Authors: Gerald T Ankley; Brett R Blackwell; Jenna E Cavallin; Jon A Doering; David J Feifarek; Kathleen M Jensen; Michael D Kahl; Carlie A LaLone; Shane T Poole; Eric C Randolph; Travis W Saari; Daniel L Villeneuve
Journal: Environ Toxicol Chem Date: 2020-02-21 Impact factor: 4.218

9. Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancer.

Authors: H R Bonnefoi; I E Smith; M Dowsett; P F Trunet; S J Houston; R J da Luz; R D Rubens; R C Coombes; T J Powles
Journal: Br J Cancer Date: 1996-02 Impact factor: 7.640

10. Arimidex (ZD1033): a selective, potent inhibitor of aromatase in postmenopausal female volunteers.

Authors: R A Yates; M Dowsett; G V Fisher; A Selen; P J Wyld
Journal: Br J Cancer Date: 1996-02 Impact factor: 7.640